Document Detail


Rehospitalization of extremely-low-birth-weight infants in first 2 years of life.
MedLine Citation:
PMID:  11834346     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: To determine whether (1) chronic lung disease (CLD) is the prime reason for extremely-low-birth-weight (ELBW) infant readmission during the first 2 years of life, (2) surfactant and other advanced therapies have reduced ELBW infant readmissions, (3) home oxygen therapy (HOT) is efficacious for this group. STUDY DESIGN: The hospital records of these ELBW infants were reviewed retrospectively. Data on age, diagnosis, treatment, and duration of each hospitalization were compiled and analyzed for their association to CLD and to readmission for CLD and other reasons. SUBJECTS: All 60 surviving infants with a birth body weight of less than 1001 g (ELBW) born from January 1993 to February 1998 were followed up to 2 years (mean 20.4 +/- 7.4 months) to evaluate their respiratory outcome. RESULTS: Forty-two percent of these infants developed CLD. Upon discharge from the hospital, 28% (7/25) of the patients were given HOT for a median period of 60 days. Of the 47 ELBW infants who were studied the entire 2-year period, 72% were readmitted. Infants with CLD were readmitted more frequently (p=0.045) and had longer hospital stays during the first 2 years of life (p=0.034) than those without CLD. Respiratory illness was the main reason for readmission (55%) of these ELBW infants. The incidence of readmission due to respiratory tract infection was not significantly different in infants with CLD (61%) and infants without respiratory complications (44%) (p=0.159). CONCLUSIONS: Infants with CLD (whether receiving HOT or not) showed no higher readmission rate due to respiratory infection, but the HOT group did have higher morbidity. The premature lung itself rather than the presence of CLD, as we would expect, makes ELBW infants more prone to readmission for respiratory illness.
Authors:
Yin Hsiu Chien; Po Nien Tsao; Hung Chieh Chou; Jen Ruey Tang; Kuo Inn Tsou
Related Documents :
10470576 - Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk p...
15274106 - Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrenty wheezy ...
11340686 - Lung volume reduction surgery in lieu of pneumonectomy in an infant with severe unilate...
747396 - Werdnig-hoffmann disease. the effects of intrauterine onset on lung growth.
19642776 - Gastroesophageal reflux in severe cases of robin sequence treated with nasopharyngeal i...
4049366 - Serum zinc and copper concentrations in low birth weight infants during first three mon...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Early human development     Volume:  66     ISSN:  0378-3782     ISO Abbreviation:  Early Hum. Dev.     Publication Date:  2002 Jan 
Date Detail:
Created Date:  2002-03-07     Completed Date:  2002-04-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7708381     Medline TA:  Early Hum Dev     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  33-40     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan 23137.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chronic Disease
Home Nursing
Humans
Infant
Infant, Newborn
Infant, Very Low Birth Weight*
Lung Diseases / therapy
Oxygen / therapeutic use
Patient Readmission*
Respiratory Tract Infections / therapy
Chemical
Reg. No./Substance:
7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rapid-eye-movement sleep in jittery infants.
Next Document:  Safety and efficacy of atorvastatin in heart transplant recipients.